Vtex
VTEX NYSE Services-Prepackaged Software Financials FY2023–FY2025
Last close · Oct 23, 2026
$4.17
0.0%What Vtex does
No business description yet.
- Legal name
- VTEX
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F · Feb 26, 2026
- Accession · CIK
- 0001193125-26-076504
0001793663
Revenue and margins
Vtex had $241M of revenue in fiscal 2025, up 6.1% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $32.3M in fiscal 2025, 13.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Vtex returned $59.1M to shareholders in fiscal 2025, 183% of free cash flow. The diluted share count fell 3.7%.
Balance sheet
Cash, debt and the ratios that show how comfortably Vtex can carry it.
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | — | $215M | $192M |
| Current ratio | — | 3.6x | 3.0x |
| Quick ratio | — | 3.6x | 3.0x |
| Total assets | — | $362M | $347M |
| Total liabilities | — | $108M | $113M |
| Shareholders' equity | $239M | $254M | $233M |
| Net debt (− = net cash) | — | — | — |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | ✕ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ |
| Return on assets rose | — | — | ✓ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ |
| Debt fell relative to assets | — | — | — |
| Current ratio rose | — | — | ✕ |
| Share count didn't rise | — | ✕ | ✓ |
| Gross margin rose | — | ✓ | ✓ |
| Revenue rose relative to assets | — | — | ✓ |
| F-score | — / 3 | — / 5 | 7 / 8 |
| Accruals ratio | — | −2.8% | −3.8% |
| Altman Z'' | — | 5.33 | 5.07 |
3 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $201M | $227M | $241M |
| Gross profit | $140M | $167M | $186M |
| Research and development | $60.2M | $55.4M | $63.9M |
| Operating income | −$14.0M | $7.4M | $18.1M |
| Pretax income | −$12.5M | $13.3M | $22.5M |
| Income tax | $3.4M | −$2.5M | $2.5M |
| Net income | −$15.8M | $15.8M | $20.0M |
| Diluted EPS | −$0.09 | $0.08 | $0.11 |
| Diluted shares | 0.00B | 0.00B | 0.00B |
| Cash flow | |||
| Cash from operations | $5.4M | $26.0M | $33.4M |
| Capital expenditure | $0.5M | $2.1M | $1.0M |
| Free cash flow | $4.9M | $23.9M | $32.3M |
| Depreciation and amortization | $4.0M | $3.2M | $3.3M |
| Stock-based compensation | $15.6M | $16.9M | $17.2M |
| Acquisitions | $0.0M | $2.9M | $3.7M |
| Share buybacks | $35.2M | $11.2M | $59.1M |
| Dividends and buybacks | $35.2M | $11.2M | $59.1M |
| Balance sheet | |||
| Cash and short-term investments | — | $215M | $192M |
| Current assets | — | $285M | $268M |
| Current liabilities | — | $80.0M | $88.0M |
| Property and equipment, net | — | $3.0M | $3.2M |
| Goodwill | $21.8M | $22.2M | $26.3M |
| Intangible assets | — | $6.8M | $7.9M |
| Total assets | — | $362M | $347M |
| Total liabilities | — | $108M | $113M |
| Shareholders' equity | $239M | $254M | $233M |
| Margins | |||
| Gross margin | 69.6% | 73.7% | 77.5% |
| Operating margin | −7.0% | 3.3% | 7.5% |
| EBITDA margin | −5.0% | 4.7% | 8.9% |
| Net margin | −7.9% | 7.0% | 8.3% |
| FCF margin | 2.5% | 10.5% | 13.4% |
| Returns | |||
| Return on capital employed | — | 2.6% | 7.0% |
| Return on equity | −6.6% | 6.4% | 8.2% |
| Return on assets | — | 4.4% | 5.6% |
| Return on tangible equity | −7.3% | 7.0% | 10.0% |
| Growth | |||
| Revenue growth | — | 12.9% | 6.1% |
| Net income growth | — | — | 26.5% |
| EPS growth | — | — | 31.7% |
| FCF growth | — | 384.6% | 35.3% |
| Share count change | — | 3.2% | −3.7% |
| Financial health | |||
| Current ratio | — | 3.6x | 3.0x |
| Quick ratio | — | 3.6x | 3.0x |
| Capital allocation | |||
| Capex / revenue | 0.2% | 0.9% | 0.4% |
| Stock comp / revenue | 7.8% | 7.4% | 7.2% |
| Payouts / FCF | 714.7% | 46.9% | 182.8% |
| Quality scores | |||
| Piotroski F-score | — | — | 7.0 |
| Altman Z'' | — | 5.3 | 5.1 |
| Accruals ratio | — | −2.8% | −3.8% |
Source: SEC EDGAR XBRL filings (CIK 0001793663). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.